Carolyn Ruth Bertozzi is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems, and is a major figure in the field of glycobiology, the study of structural carbohydates or glycans. Her work focuses on developing tools of analytical chemistry to study glycans and their role in diseases such as cancer, inflammation, and viral infections like COVID-19. At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory. Since 2024, she has served as a scientific advisory board member of Arc Institute. The Nobel Prize in Chemistry 2022, announced October 5, 2022. Carolyn Bertozzi, Morten Meldal, and K. Barry Sharpless, “for the development of click chemistry and bioorthogonal chemistry”. Carolyn Bertozzi: born 1966, Boston, MA, USA. Morten Meldal: born 1954, Copenhagen, Denmark. K. Barry Sharpless: born 1941, Philadelphia, PA, USA. Wiki link Wiki link Wiki link Data: the Nobel Foundation (CC0).